Vaccine
India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters. The source, who did not want to be named as the i..
The Ministry of Public Health (MOPH) has announced that more than 125,000 COVID-19 vaccine booster doses have been safely administered in the last seven days as the roll out of booster doses picks up pace. Anyone aged 12 years and above who had th..
Austria will become the first European country to make vaccination compulsory for adults in February, Chancellor Karl Nehammer said, acknowledging that it was a "sensitive topic". Nehammer, a conservative who took office in December, sai..
Unvaccinated people infected with the Omicron variant of coronavirus may be less prone to severe illness and requiring hospital care or dying than was the case with previous variants, a South African study showed on Friday. The study, by the Natio..
The Qatar Vaccination Center for Business and Industry Sector in Bu Garn has administered more than 100,000 COVID-19 vaccine doses since opening on January 9, the Hamad Medical Corporation has said. The centre administers COVID-19 vaccines to key ..
The Ministry of Public Health has approved the administration of Pfizer-BioNTech COVID-19 booster vaccines for children aged 12 to 15 years. The decision is in line with the recent studies that demonstrate the safety and efficacy of booster doses ..
Serum Institute Of India has applied to the country's drug regulator and the health ministry for full approval of its COVID-19 vaccine Covishield, the company's chief executive said on Friday. Serum Institute, which produces AstraZeneca..
Serum Institute Of India has applied to the country's drug regulator and the health ministry for full approval of its COVID-19 vaccine Covishield, the company's chief executive said on Friday. Serum Institute, which produces AstraZeneca..
Research by South African scientists suggests that Omicron could displace the Delta variant of the coronavirus because infection with the new variant boosts immunity to the older one. The study only covered a small group of people and has not been..